Cite

HARVARD Citation

    Meuth, S. et al. (2022). Long-term management of multiple sclerosis patients treated with cladribine tablets beyond year 4. Expert opinion on pharmacotherapy. pp. 1503-1510. [Online]. 
  
Back to record